Not approved for human or animal administration, therapeutic, or diagnostic applications
If patients experience severe gastrointestinal symptoms or dehydration, stopping GLP-1 therapy temporarily is advisable
Mild redness, swelling, peeling, and temporary pigment darkening can happen after treatment
Our L-Carnitine 600mg is manufactured under strict quality-controlled conditions and undergoes 99% HPLC-tested peptide purity verification standards
Gastrointestinal effects such as nausea, early satiety, and changes in bowel habits are common, though typically transient and improved with gradual dose titration [30]
A review of the effects of glucagon-like Peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans